Literature DB >> 15114374

Application of microarrays to the analysis of the inactivation status of human X-linked genes expressed in lymphocytes.

Ian W Craig1, Jonathan Mill, Gavin M Craig, Caroline Loat, Leonard C Schalkwyk.   

Abstract

Dosage compensation in mammalian females is achieved by the random inactivation of one X chromosome early in development; however, inactivation is not complete. In addition to a majority of pseudoautosomal loci, there are genes that are expressed from both the active and the inactive X chromosomes, and which are interspersed among other genes subject to regular dosage compensation. The patterns of X-linked gene expression in different tissues are of great significance for interpreting their impact on sex differences in development. We have examined the suitability and sensitivity of a microarray approach for determining the inactivation status of X-linked genes. Biotinylated cRNA from six female and six male lymphocyte samples were hybridised to Affymetrix HG-U133A microarrays. A total of 36 X-linked targets detected significantly higher levels of female transcripts, suggesting that these corresponded to sequences from loci that escaped, at least partly, from inactivation. These included genes for which previous experimental evidence, or circumstantial evidence, existed for their escape, and some novel candidates. Six of the targets were represented by more than one probe set, which gave independent support for the conclusions reached.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15114374     DOI: 10.1038/sj.ejhg.5201212

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  12 in total

1.  Monoallelic expression of MAO-A in skin fibroblasts.

Authors:  N Nordquist; L Oreland
Journal:  J Neural Transm (Vienna)       Date:  2007-04-04       Impact factor: 3.575

Review 2.  X-chromosome inactivation: molecular mechanisms from the human perspective.

Authors:  Christine Yang; Andrew G Chapman; Angela D Kelsey; Jakub Minks; Allison M Cotton; Carolyn J Brown
Journal:  Hum Genet       Date:  2011-05-07       Impact factor: 4.132

3.  Inactivation status of PCDH11X: sexual dimorphisms in gene expression levels in brain.

Authors:  Alexandra M Lopes; Norman Ross; James Close; Adam Dagnall; António Amorim; Timothy J Crow
Journal:  Hum Genet       Date:  2006-01-20       Impact factor: 4.132

4.  Overall and allele-specific expression of the SMC1A gene in female Cornelia de Lange syndrome patients and healthy controls.

Authors:  Ilaria Parenti; Davide Rovina; Maura Masciadri; Anna Cereda; Jacopo Azzollini; Chiara Picinelli; Giuseppe Limongelli; Palma Finelli; Angelo Selicorni; Silvia Russo; Cristina Gervasini; Lidia Larizza
Journal:  Epigenetics       Date:  2014-04-22       Impact factor: 4.528

5.  Neural growth hormone implicated in body weight sex differences.

Authors:  Paul J Bonthuis; Emilie F Rissman
Journal:  Endocrinology       Date:  2013-07-16       Impact factor: 4.736

6.  Variations in the four and a half LIM domains 1 gene (FHL1) are associated with fasting insulin and insulin sensitivity responses to regular exercise.

Authors:  M Teran-Garcia; T Rankinen; T Rice; A S Leon; D C Rao; J S Skinner; C Bouchard
Journal:  Diabetologia       Date:  2007-06-23       Impact factor: 10.122

Review 7.  Dosage compensation and gene expression on the mammalian X chromosome: one plus one does not always equal two.

Authors:  Katie E Prothero; Jill M Stahl; Laura Carrel
Journal:  Chromosome Res       Date:  2009       Impact factor: 5.239

Review 8.  Monosomy for the X chromosome.

Authors:  Carolyn A Bondy; Clara Cheng
Journal:  Chromosome Res       Date:  2009       Impact factor: 5.239

9.  Dysregulation of X-linked gene expression in Klinefelter's syndrome and association with verbal cognition.

Authors:  Marquis P Vawter; Philip D Harvey; Lynn E DeLisi
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-09-05       Impact factor: 3.568

10.  Large-scale population study of human cell lines indicates that dosage compensation is virtually complete.

Authors:  Colette M Johnston; Frances L Lovell; Daniel A Leongamornlert; Barbara E Stranger; Emmanouil T Dermitzakis; Mark T Ross
Journal:  PLoS Genet       Date:  2007-12-13       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.